Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted axillary dissection: worldwide variations in clinical practice.
Kontos M, Kanavidis P, Kühn T, Masannat Y, Gulluoglu B; TAD Study Group. Kontos M, et al. Among authors: kuhn t. Breast Cancer Res Treat. 2024 Apr;204(2):389-396. doi: 10.1007/s10549-023-07204-7. Epub 2024 Jan 4. Breast Cancer Res Treat. 2024. PMID: 38175449
Current Evolutions in Axillary Management.
Kühn T, Rubio IT, Gentilini OD, Smidt M, Classe JM. Kühn T, et al. Breast Care (Basel). 2022 Dec;17(6):588-589. doi: 10.1159/000527823. Epub 2022 Dec 5. Breast Care (Basel). 2022. PMID: 36590147 Free PMC article. No abstract available.
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).
Banys-Paluchowski M, Kühn T, Masannat Y, Rubio I, de Boniface J, Ditsch N, Karadeniz Cakmak G, Karakatsanis A, Dave R, Hahn M, Potter S, Kothari A, Gentilini OD, Gulluoglu BM, Lux MP, Smidt M, Weber WP, Aktas Sezen B, Krawczyk N, Hartmann S, Di Micco R, Nietz S, Malherbe F, Cabioglu N, Canturk NZ, Gasparri ML, Murawa D, Harvey J. Banys-Paluchowski M, et al. Among authors: kuhn t. Cancers (Basel). 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173. Cancers (Basel). 2023. PMID: 36831516 Free PMC article. Review.
Real de-escalation or escalation in disguise?
Banys-Paluchowski M, Rubio IT, Ditsch N, Krug D, Gentilini OD, Kühn T. Banys-Paluchowski M, et al. Among authors: kuhn t. Breast. 2023 Jun;69:249-257. doi: 10.1016/j.breast.2023.03.001. Epub 2023 Mar 4. Breast. 2023. PMID: 36898258 Free PMC article.
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
de Boniface J, Filtenborg Tvedskov T, Rydén L, Szulkin R, Reimer T, Kühn T, Kontos M, Gentilini OD, Olofsson Bagge R, Sund M, Lundstedt D, Appelgren M, Ahlgren J, Norenstedt S, Celebioglu F, Sackey H, Scheel Andersen I, Hoyer U, Nyman PF, Vikhe Patil E, Wieslander E, Dahl Nissen H, Alkner S, Andersson Y, Offersen BV, Bergkvist L, Frisell J, Christiansen P; SENOMAC Trialists’ Group; SENOMAC Trialists' Group. de Boniface J, et al. Among authors: kuhn t. N Engl J Med. 2024 Apr 4;390(13):1163-1175. doi: 10.1056/NEJMoa2313487. N Engl J Med. 2024. PMID: 38598571 Clinical Trial.
Axillary clearance and chemotherapy rates in ER+HER2- breast cancer: secondary analysis of the SENOMAC trial.
Tvedskov TF, Szulkin R, Alkner S, Andersson Y, Bergkvist L, Frisell J, Gentilini OD, Kontos M, Kühn T, Lundstedt D, Offersen BV, Bagge RO, Reimer T, Sund M, Rydén L, Christiansen P, de Boniface J; SENOMAC Trialists' Group. Tvedskov TF, et al. Among authors: kuhn t. Lancet Reg Health Eur. 2024 Sep 26;47:101083. doi: 10.1016/j.lanepe.2024.101083. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39386258 Free PMC article.
Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery.
Pochert N, Schneider M, Köpke MB, Wild M, Mattmer A, Sagasser J, Golas MM, Banys-Paluchowski M, Metz A, Hinske C, Reiger M, Jeschke U, Dannecker C, Neumann A, Traidl-Hoffmann C, Untch M, Kühn T, Ditsch N. Pochert N, et al. Among authors: kuhn t. Arch Gynecol Obstet. 2023 Nov;308(5):1621-1627. doi: 10.1007/s00404-023-07074-w. Epub 2023 May 27. Arch Gynecol Obstet. 2023. PMID: 37243864 Free PMC article.
Palbociclib in combination with either aromatase inhibitors or fulvestrant for patients with advanced HR+/HER2- breast cancer in Germany - Final results of the phase 2 multicohort INGE-B trial.
Welslau M, Potthoff K, Zaiss M, Müller L, Brucker C, Salat C, Untch M, Meiler J, Lüftner D, Welt A, Dörfel S, Hagen V, Stein A, Liersch R, Kuhn T, Siebenbach HU, Bing G, Vannier C, Marschner N, Gratzke K. Welslau M, et al. Among authors: kuhn t. Oncol Res Treat. 2024 Nov 15:1-20. doi: 10.1159/000542459. Online ahead of print. Oncol Res Treat. 2024. PMID: 39551040 Free article.
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.
Montagna G, Laws A, Ferrucci M, Mrdutt MM, Sun SX, Bademler S, Balbaloglu H, Balint-Lahat N, Banys-Paluchowski M, Barrio AV, Benson J, Bese N, Boughey JC, Boyle MK, Diego EJ, Eden C, Eller R, Goldschmidt M, Hlavin C, Heidinger M, Jelinska J, Karadeniz Cakmak G, Kesmodel SB, King TA, Kuerer HM, Loesch J, Milardi F, Murawa D, Moo TA, Menes TS, Passeri D, Pastoriza JM, Perhavec A, Pislar N, Polidorio N, Rami A, Ryu JM, Schulz A, Sevilimedu V, Ugurlu MU, Uras C, van Hemert A, Wong SM, Yoo TR, Zhang JQ, Karanlik H, Cabioğlu N, Peeters MV, Morrow M, Weber WP; ICARO Study Group. Montagna G, et al. J Clin Oncol. 2024 Nov 7:JCO2401052. doi: 10.1200/JCO.24.01052. Online ahead of print. J Clin Oncol. 2024. PMID: 39509672
881 results